SMITH & NEPHEW PLC ORD USD0.20 (SN.L) Financials
SN.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 783.9 billion | 374.4 billion |
| 2023-07-01 | ? | ? |
| 2023-06-30 | 779.8 billion | 365.2 billion |
| 2023-04-01 | 796.8 billion | 373.2 billion |
SN.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-07-01 | -2.1 billion | 746.9 million |
| 2023-06-30 | ? | ? |
| 2023-04-01 | -2.2 billion | 768.9 million |
SN.L Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | ? |
| 2023-07-01 | 6.8 billion |
| 2023-06-30 | ? |
| 2023-04-01 | 7.0 billion |
SN.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 23.7 billion | - | 15.6 billion |
| 2023-07-01 | - | - | - |
| 2023-06-30 | 15.1 billion | - | 15.3 billion |
| 2023-04-01 | 15.4 billion | - | - |
SN.L Shares Outstanding
SN.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-07-01 | 6.6 billion | 6.5 billion | - | - |
| 2023-06-30 | - | - | - | - |
| 2023-04-01 | 6.8 billion | 6.7 billion | - | - |
SN.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-07-01 | 107.5 billion | 32.9 billion |
| 2023-06-30 | - | - |
| 2023-04-01 | 110.6 billion | 33.8 billion |
SN.L
Price: £9.97
Dividend Yield: 0.00%
Forward Dividend Yield: 4.63%
Payout Ratio: 19250.00%
Dividend Per Share: 46.20 GBp
Earnings Per Share: 0.24 GBp
P/E Ratio: 54.87
Exchange: LSE
Sector: Healthcare
Industry: Medical Devices
Volume: 801389
Market Capitalization: 8.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 32
DGR3: 8.83%
DGR5: 30.00%
DGR10: 29.28%
DGR20: 20.27%